1 | Treatment of relapsed classical Hodgkin lymphoma in the Brentuximab vedoitn era. | |
Page 1-8 | ||
Emad A Abdelhady | ||
2 | B-cell-receptor-targeted therapy in CLL | |
Page 9-18 | ||
Haitham M AbdelBary | ||
3 | Current issues in chronic graft versus host disease | |
Page 19-30 | ||
Amr M ElGhammaz | ||
4 | Fibrinogen as a replacement therapy in bleeding disorder | |
Page 31-35 | ||
Rasha M Mohamed Said | ||
5 | Secondary Monoclonal Gammopathy of Undetermined Significance: A Sign Of Cure Or A Harbinger Of Relapse. | |
Page 36-40 | ||
Alia M. Saeed | ||
6 | Epigenetics in Hematological Malignancies | |
Page 41-50 | ||
Mostafa K ElRazzaz | ||
7 | Prevention of venous thromboembolism in cancer patients | |
Page 51-57 | ||
Haydi M Mohamed | ||